Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with no efficacious treatment. The application of nanomedicine is expected to bring new hope to PDAC treatment. In this study, we report a novel supramolecular dendrimeric nanosystem carrying the anticancer drug doxorubicin, which demonstrated potent anticancer activity, markedly overcoming the heterogeneity of drug response and resistance of primary cultured tumor cells derived from PDAC patients. This dendrimer nanodrug was constructed with a fluorinated amphiphilic dendrimer, which self-assembled into micelles nanostructure and encapsulated doxorubicin with high loading. Because of the fine nanosize, stable formulation and acid-promoted drug release, this dendrimeric nanosystem effectively accumulated in tumor, with deep penetration in tumor tissue and rapid drug uptake/release profile in cells, ultimately resulting in potent anticancer activity and complete suppression of tumor growth in patient-derived xenografts. Most importantly, this dendrimer nanodrug generated uniform and effective response when treating 35 primary pancreatic cancer cell lines issued from patient samples as a robust platform for preclinical drug efficacy testing. In addition, this dendrimer nanodrug formulation was devoid of adverse effects and showed excellent tolerability. Given all these uniquely advantageous features, this simple and convenient dendrimer nanodrug holds great promise as a potential candidate to treat the deadly PDAC.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291567 | PMC |
| http://dx.doi.org/10.1002/EXP.20210003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Inhibition of HIV-1 infection with curcumin conjugated PEG-citrate dendrimer; a new nano formulation.
BMC Complement Med Ther
October 2024
Department of Medical Lab Technology, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Article Synopsis
- Scientists are studying a special tiny delivery system called dendrimers to help get more effective medicine into cells, like curcumin, which can help fight viruses like HIV-1.
- They created a new type of dendrimer that can make curcumin more dissolvable in water and easier for cells to absorb.
- The tests showed that this curcumin-dendrimer combination can significantly stop HIV from growing, making it a strong candidate for future treatments.
Antimalarial Effects of Nano Chloroquine Loaded Curcumin In vivo.
Infect Disord Drug Targets
September 2024
Department of Parasitology, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.
Article Synopsis
- Malaria, caused by Plasmodium spp., remains a leading parasitic threat, prompting researchers to explore innovative and safer antimalarial alternatives like nanodrugs due to issues with drug resistance and side effects from conventional treatments.
- The study focused on a novel treatment, a nonochloroquine-loaded curcumin using dendrimer G2, assessing its effectiveness and safety in BALB/C mice.
- Results indicated that this new nanocomposite had a significant inhibitory effect on malaria at a dosage of 10 mg/kg, outperforming traditional chloroquine, with no harmful effects reported, suggesting potential for further research and clinical trials.
Nanocosmeceuticals: Trends and Recent Advancements in Self Care.
AAPS PharmSciTech
February 2024
Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow, 226031, India.
The term cosmetics refers to any substances or products intended for external application on the skin with the aim of protection and better appearance of the skin surface. The skin delivery system promotes the controlled and targeted delivery of active ingredients. The development of this system has been driven by challenges encountered with conventional cosmeceuticals, including low skin retention of active components, limited percutaneous penetration, poor water dispersion of insoluble active ingredients, and instability of effective components.
View Article and Find Full Text PDFMultimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy.
Proc Natl Acad Sci U S A
February 2024
Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139.
Integrating multimodal neuro- and nanotechnology-enabled precision immunotherapies with extant systemic immunotherapies may finally provide a significant breakthrough for combatting glioblastoma (GBM). The potency of this approach lies in its ability to train the immune system to efficiently identify and eradicate cancer cells, thereby creating anti-tumor immune memory while minimizing multi-mechanistic immune suppression. A critical aspect of these therapies is the controlled, spatiotemporal delivery of structurally defined nanotherapeutics into the GBM tumor microenvironment (TME).
View Article and Find Full Text PDFRecent Advances in Micro- and Nano-Drug Delivery Systems Based on Natural and Synthetic Biomaterials.
Polymers (Basel)
November 2023
Department of Applied Chemistry, Graduate School of Engineering, University of Hyogo, 2167 Shosha, Himeji 671-2280, Hyogo, Japan.
Article Synopsis
- Polymeric drug delivery technology has significantly improved, making it easier for medicines to enter cells, with highlighted applications of biodegradable and bio-reducible polymers.
- Natural polymers like chitosan and hyaluronic acid, along with synthetic options such as dendritic and bioabsorbable polymers, are being utilized in innovative drug delivery methods.
- The combination of synthetic and biological materials is leading to advanced micro- and nano-drug delivery systems, which have shown potential in treating diseases, including cancer.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!